Kaya, Özge (2023) “Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?”, Dermatology Practical & Conceptual, 13(3), p. e2023145. doi:10.5826/dpc.1303a145.